Atlantic Union Bankshares’s Bionano Genomics BNGO Stock Holding History

Atlantic Union Bankshares’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	1	–	–	﹤0.01%	1698
2026 Q1	$1	Buy	+1	New	+$1	﹤0.01%	1748

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Atlantic Union Bankshares's BNGO Position: Q2 2026 in Review

Atlantic Union Bankshares held its Bionano Genomics (BNGO) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1698.

Atlantic Union Bankshares first reported a position in BNGO in Q1 2026 and has held it in 2 quarters since. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

Atlantic Union Bankshares held 1 share of Bionano Genomics worth $1 as of Q2 2026.
Atlantic Union Bankshares left its Bionano Genomics share count unchanged in Q2 2026.
Bionano Genomics made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #1698 holding.
Atlantic Union Bankshares first reported a position in Bionano Genomics in Q1 2026 and has held it in 2 quarters since.
34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.